Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: A 25-year prospective study

Breast Cancer Research and Treatment

Volumn 98, Issue 1, 2006, Pages 63-70

  Buehring, Gertrude Case ^a   Letscher, Amy ^a   McGirr, Kathleen M ^a   Khandhar, Shruti ^a   Che, Lisa H ^a   Nguyen, Christine T ^a   Hackett, Adeline J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer risk; Epithelial cells; Nipple aspirate fluid

Indexed keywords

ADULT; ARTICLE; ASPIRATION BIOPSY; BODY FLUID; BREAST BIOPSY; BREAST CANCER; BREAST EPITHELIUM; BREAST TUMOR; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; EARLY DIAGNOSIS; EPITHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NIPPLE; NIPPLE ASPIRATE FLUID; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; BIOPSY, NEEDLE; BODY FLUIDS; BREAST NEOPLASMS; COHORT STUDIES; EPITHELIAL CELLS; FEMALE; HUMANS; MIDDLE AGED; NIPPLES; PROSPECTIVE STUDIES; RISK; TUMOR MARKERS, BIOLOGICAL;

EID: 33745892402     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9132-5     Document Type: Article

References (26)

1. Koss LG: Diagnostic Cytology. JB Lippincott, Philadelphia, 1968 541
2. Haagensen CD: Diseases of the Breast. 2nd ed. WB Saunders, Philadelphia, 1971
3. Vorherr H: The Breast. Academic Press, New York, 1974 218-246
4. Papanicolaou GN, Holmquist DG, Bader FM, Falk EA: Exfoliative cytology of the human mammary gland and its value in the diagnosis of cancer and other diseases of the breast. Cancer 1: 377-409, 1958
5. Sartorius OW, Smith HS, Morris P, Benedict D, Friesen L: Cytological evaluation of breast fluid in the detection of breast diseases. J Natl Cancer Inst 59: 1073-1108, 1977
6. Petrakis NL, Mason L, Lee R, Sugimoto B, Pawson S, Catchpool F: Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nipple aspiration. J Natl Cancer Inst 54: 829-834, 1975
7. Buehring GC: Screening for breast atypias using exfoliative cytology. Cancer 43: 1788-1799, 1979
8. Wrensch MR, Petrakis NL, King EB, Miike R, Mason L, Chew K, Lee MM, Ernster VL, Hilton JF, Schweitzer R, Goodson WH III, Hunt TK: Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidem 135: 130-141, 1992
9. Wrensch MR, Petrakis NL, King EB, Lee MM, Miike R: Breast cancer risk associated with abnormal cytology in nipple aspirates of breast fluid and prior history of breast biopsy. Am J Epidem 137: 829-833, 1993
10. Wrensch MR, Petrakis NL, Miike R, King EB, Chew K, Neuhaus J, Lee MM, Rhys M: Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst 93: 1791-1798, 2001
11. Papanicolaou GN: New procedure for staining vaginal smears. Science 95: 438-439, 1942
12. Fitzgibbons PL, Henson DE, Hutter RVP, for the Cancer Committee of the College of American Pathologists. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Arch Pathol Lab Med 122: 1053-1055, 1998
13. Coleman EA, O'Sullivan PO: Racial differences in breast cancer screening among women from 65-74 years of age: trends from 1987-1993 and barriers to screening. J Women Aging 13: 23-39, 2001
14. Harris DM, Miller JE, Davis DM: Racial differences in breast cancer screening, knowledge and compliance. J Natl Med Asscoc 95: 693-701, 2003
15. Katapodi MC, Faclone NC, Miakowski C, Dodd MJ, Waters C: The influence of social support on breast cancer screening in a multicultural community sample. Oncol Nurs Forum 29: 845-852, 2002
16. Vernon SW, Vogel VG, Halabi A, Jackson GL, Lundy RO, Peters GN: Breast cancer screening behaviors and attitudes in three racial/ethnic groups. Cancer 69: 165-174, 1992
17. Zou G: A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 159: 702-706, 2004
18. MacMahon B, Cole P, Brown J: Etiology of human breast caner: a review. J Natl Cancer Inst 50: 21-42, 1973
19. California Cancer Registry: Breast Cancer in California, 2003
20. Ganguli M, Lytle ME, Reynolds MD, Dodge HH: Random vs. volunteer selection for a community-based study. J Gerontol: Series A, Biol Sci Med Sci 53: M39-M46, 1998
21. King E, Barrett D, Petrakis NL: Cellular composition of the nipple aspirate specimen of breast fluid. II. Abnormal findings. Am J Natl Clin Pathol 64: 739-748, 1975
22. Fournier DV, Weber E, Hoeffken W, Bauer M, Kubli F, Barth V: Growth rate of 147 mammary carcinomas. Cancer 45: 2198-2207, 1980
23. Lundgren B: Observations on growth rate of breast carcinomas and its possible implications for lead time. Cancer 40: 1722-1725, 1977
24. Wellings SR, Jensen HM, Marcum RG: An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55: 231-273, 1975
25. Page DL: The woman at high risk for breast cancer: importance of hyperplasia. Surg Clin N Am 76: 221-230, 1996
26. Fabian CJ, Kimler BF, Mayo MS, Khan SA: Breast-tissue sampling for risk assessment and prevention. Endocr-relat Cancer 12: 185-213, 2005